home / stock / tdsgf / tdsgf quote
Last: | $0.116 |
---|---|
Change Percent: | 5.17% |
Open: | $0.11 |
Close: | $0.116 |
High: | $0.116 |
Low: | $0.1 |
Volume: | 15,000 |
Last Trade Date Time: | 04/30/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.116 | $0.11 | $0.116 | $0.116 | $0.1 | 15,000 | 04-30-2024 |
$0.13 | $0.13 | $0.13 | $0.13 | $0.13 | 2,500 | 04-29-2024 |
$0.1232 | $0.1299 | $0.1232 | $0.1299 | $0.1232 | 30,000 | 04-26-2024 |
$0.1433 | $0.1433 | $0.1433 | $0.1433 | $0.1433 | 1,000 | 04-25-2024 |
$0.1233 | $0.1322 | $0.1233 | $0.1322 | $0.1233 | 50,000 | 04-24-2024 |
$0.12995 | $0.15 | $0.12995 | $0.15 | $0.1292 | 74,000 | 04-23-2024 |
$0.1477 | $0.1477 | $0.1477 | $0.1609 | $0.1477 | 16,000 | 04-22-2024 |
$0.1247 | $0.149 | $0.1247 | $0.149 | $0.11325 | 44,700 | 04-19-2024 |
$0.1502 | $0.1502 | $0.1502 | $0.1502 | $0.1502 | 5,000 | 04-18-2024 |
$0.15 | $0.15 | $0.15 | $0.15 | $0.15 | 10,000 | 04-15-2024 |
$0.1406 | $0.1336 | $0.1406 | $0.1406 | $0.1336 | 7,883 | 04-11-2024 |
$0.1336 | $0.1304 | $0.1336 | $0.1336 | $0.1121 | 111,753 | 04-10-2024 |
$0.1025 | $0 | $0.1025 | $0 | $0 | 30,050 | 04-09-2024 |
$0.1025 | $0.098 | $0.1025 | $0.1048 | $0.098 | 37,400 | 04-08-2024 |
$0.0889 | $0.0889 | $0.0889 | $0.0889 | $0.0889 | 80,365 | 04-02-2024 |
$0.0829 | $0.0829 | $0.0829 | $0.0829 | $0.0829 | 1,500 | 03-29-2024 |
$0.0829 | $0.0829 | $0.0829 | $0.0829 | $0.0829 | 1,500 | 03-28-2024 |
$0.0826 | $0.0826 | $0.0826 | $0.0826 | $0.0826 | 620 | 03-26-2024 |
$0.0899 | $0 | $0.0899 | $0 | $0 | 70 | 03-21-2024 |
$0.0899 | $0.0899 | $0.0899 | $0.0899 | $0.0899 | 3,400 | 03-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
Teledata Singapore Ltd Company Name:
TDSGF Stock Symbol:
OTCMKTS Market:
Toronto, Ontario--(Newsfile Corp. - April 10, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications measuring genomic instability in oncol...
Toronto, Ontario--(Newsfile Corp. - April 2, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications measuring genomic instability in oncolo...
Toronto, Ontario--(Newsfile Corp. - February 13, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") is pleased to announce that it has received the first patient sample for its clinical trial monitoring multiple myeloma ("MM") disease progression in post-treat...